Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Dose vs Standard Dose of Indocyanine Green in Near-infrared Fluorescence Cholangiography During Laparoscopic Cholecystectomy
NCT07195331Phase 4Recruiting
- Sponsor
- Hospital Universitario de Salamanca
- Start
- Feb 2026
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indocyanine green in cholelithiasis, gallbladder polyps, sponsored by Hospital Universitario de Salamanca. Started Feb 2026; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
cholelithiasisgallbladder polyps
Beyond the preview
Go deeper on NCT07195331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07195331.